• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-07-29

  Xu et al. present a radiosensitizing strategy using EGCG-based nanoparticles (BENPs) to amplify anti-tumor effects of ultra-high dose rate radiotherapy (FLASH-RT). Their study demonstrates that BENPs promote DNA double-strand breaks and strengthen antitumor immune responses, addressing a key limitation of FLASH-RT and offering translational insights for cancer therapy.

• Ciprofloxacin Hydrochloride: Mechanistic Insights for Transl

  2026-07-29

  This article explores the mechanistic underpinnings and translational opportunities of ciprofloxacin hydrochloride, integrating single-cell insights with workflow guidance for researchers. Drawing on recent evidence and comparative studies, we offer a strategic perspective for maximizing the value of this fluoroquinolone antibiotic in advanced antibacterial and immunomodulatory research.

• γH2AX DNA Damage Detection: Advancing Precision in FLASH-RT

  2026-07-28

  Explore the γH2AX DNA Damage Detection Kit as a cutting-edge tool for quantifying DNA damage and repair, with a special focus on integrating DNA damage biomarker γ-H2AX into next-generation radiotherapy research. Uncover unique insights into FLASH-RT, radiosensitization, and immune modulation for translational oncology.

• PreScission Protease (PSP): Practical Guide for Tag Cleavage

  2026-07-28

  PreScission Protease (PSP) enables efficient and specific removal of fusion tags from recombinant proteins, helping researchers recover native proteins without harsh conditions. It is best suited for workflows requiring precise tag cleavage at low temperatures. PSP should not be used for broad-spectrum proteolysis or non-canonical cleavage sites.

• LKB1 Suppresses Telomerase via Histone Lactylation in Lung A

  2026-07-27

  This study uncovers a mechanism by which LKB1 impedes telomerase activity and induces cellular senescence in lung adenocarcinoma, mediated through histone lactylation and Sp1-dependent transcriptional repression. The findings clarify LKB1’s role in tumor suppression and provide new insights for designing senescence-based cancer therapies.

• SR-202 in Insulin Resistance & Obesity: Protocols and Pitfal

  2026-07-27

  SR-202 enables researchers to precisely dissect PPARγ-dependent mechanisms in metabolic and immunometabolic disease models. This guide translates cutting-edge bench findings into optimized workflows, troubleshooting strategies, and actionable protocol parameters for advanced insulin resistance and anti-obesity research.

• Gentamycin Sulfate (A2514): Reliable Solutions for Resistanc

  2026-07-26

  This article addresses real-world challenges in bacterial protein synthesis research, focusing on how Gentamycin Sulfate (SKU A2514) enables reproducible, high-fidelity assays in the context of Gram-negative resistance. Drawing on validated protocols and comparative insights, it demonstrates the reagent’s utility and reliability for biomedical researchers and laboratory scientists.

• Cimetidine as a Histamine-2 Antagonist: Mechanistic Insights

  2026-07-25

  Discover how Cimetidine, a distinct histamine-2 receptor antagonist, advances high-throughput blood-brain barrier (BBB) modeling and cancer research. This article highlights mechanistic nuances, protocol guidance, and the latest translational findings.

• Jasplakinolide: Strategic Leverage in Translational Actin Bi

  2026-07-24

  This thought-leadership article dissects the mechanistic and strategic value of Jasplakinolide for translational researchers. It blends molecular insight, competitive benchmarking, and actionable workflow guidance to empower next-generation cytoskeletal discovery.

• UHRF1-Mediated DNA Methylation Alters Super-Enhancers in Ost

  2026-07-24

  This study uncovers how UHRF1-driven DNA 5-mC modification disrupts super-enhancer landscapes in mesenchymal stem cells, impairing osteogenesis in senile osteoporosis. The findings integrate multi-omics data to reveal a mechanistic link between epigenetic regulation, enhancer dynamics, and skeletal aging, highlighting new research and therapeutic targets.

• Müller Cell PEDF Modulates Angiopoietin-Mediated Retinal Neu

  2026-07-23

  This study reveals that Müller cell-derived pigment epithelium-derived factor (PEDF) plays a pivotal role in regulating retinal neuron survival through angiopoietin (Ang)-mediated signaling. The work elucidates how Ang-1 and Ang-2 differentially influence Tie-2/PI3K/Akt pathways and PEDF expression, offering mechanistic insight with translational potential for neurovascular retinal disorders.

• Cefiderocol vs. Cefepime: In Vitro Resistance in Enterobacte

  2026-07-23

  This study profiles the in vitro activity of cefiderocol against European Enterobacterales, including challenging isolates resistant to meropenem and β-lactam/β-lactamase inhibitor combinations. Key findings highlight cefiderocol’s superior efficacy against multidrug-resistant strains, underscoring the importance of early susceptibility testing and providing a new framework for modeling antimicrobial resistance in research.

• Dorsomorphin 2HCl: AMPK Inhibitor Workflows in Metabolic Res

  2026-07-22

  Dorsomorphin 2HCl enables precise dissection of AMPK and BMP signaling in metabolic and osteogenic research. Discover workflow enhancements, troubleshooting, and protocol best practices drawn from cutting-edge studies and preclinical models.

• Temozolomide (SKU B1399): Reliable DNA Damage for Cancer Mod

  2026-07-22

  This article delivers an evidence-based, scenario-driven guide for leveraging Temozolomide (SKU B1399) as a reproducible small-molecule alkylating agent in cell viability and DNA repair studies. Through real laboratory scenarios, it demonstrates how Temozolomide's validated solubility, performance, and supply chain reliability from APExBIO translate to higher-quality, interpretable results for cancer model research.

• Chlorambucil (SKU B3716): Reliable DNA Crosslinking in Oncol

  2026-07-21

  This article addresses common laboratory challenges in cell viability and cytotoxicity assays, focusing on the reproducibility and mechanistic clarity provided by Chlorambucil (SKU B3716). By dissecting five real-world scenarios, it demonstrates how APExBIO’s high-purity Chlorambucil supports robust experimental design, precise dose-response characterization, and consistent assay performance for cancer researchers.

14710 records 1/981 page Next 12345 下5页 Last page